Adults with sickle cell anemia showed poorer performance on neurocognitive tests.

Anemia was associated with poorer neurocognitive function in old patients. ‘Adult patients with SCA who are neurologically asymptomatic are still at risk for neurocognitive performance deficits, because their anemia may be inducing neurocognitive impairment secondary to cerebral hypoxemia [deficient oxygen in the blood] undetectable by standard neuroimaging studies. Several practical steps can be taken. First, early identification of patients with difficulties on particular methods of neurocognitive function may enable these patients to sign up in and reap the benefits of cognitive rehabilitation programs.The chance for CSME was also a substantial 1.89 times higher among patients in the 5 to 14-year age group weighed against their younger counterparts. Puberty had no significant influence on CSME incidence, notice Groop et al, with a marginal and nonsignificantly higher rate of the eye condition among 6 to 11 year-olds weighed against their 12 to 18 year-old peers, at 30 percent versus 24 percent. The results suggest that age group at onset of type 1 diabetes may modify the chance of CSME in type 1 diabetes individuals by affecting the age of which patients become vunerable to microvascular problems, conclude the authors. Certified from medwireNews with authorization from Springer Healthcare Ltd. All privileges reserved.